| Dopamine agonists for preventing future miscarriage in women with high prolactin levels and a history of recurrent miscarriage |
| Dopamine agonists for restless legs syndrome |
| Dopamine agonists for the treatment of people who misuse cocaine |
| Dopamine agonists for traumatic brain injury |
| Dopamine agonists to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction technology |
| Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia |
| Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies |
| Dopamine versus dobutamine for hypotensive preterm infants |
| Dopamine versus no treatment to prevent renal dysfunction in indomethacin-treated preterm newborn infants |
| Dopaminergic agents versus control for enhancing stroke recovery and rehabilitation |
| Dopaminergic antagonists for alcohol dependence |
| Doppler trans-thoracic echocardiography for detection of pulmonary hypertension in adults |
| Doppler ultrasound for fetal assessment in high risk pregnancies |
| Doppler ultrasound of blood vessels in the placenta and uterus of pregnant women as a way of improving outcome for babies and their mothers |
| Doppler ultrasound of fetal blood vessels in normal pregnancies |
| Doppler ultrasound of fetal vessels in pregnancies at increased risk of complications |
| Doppler ultrasound, CT angiography, MR angiography, and contrast-enhanced MR angiography versus intra-arterial angiography for moderate and severe carotid stenosis in symptomatic patients |
| Dornase alfa, an inhaled drug, for treating lung disease in cystic fibrosis |
| Dosage intervals of amoxicillin for the treatment of acute middle ear infection |
| Dose-escalated radiotherapy for clinically localised and locally advanced prostate cancer |
| Dosing regimens for pancreatic enzyme replacement therapy (PERT) in cystic fibrosis |
| Double gloving to reduce surgical cross-infection |
| Double wall versus single wall incubator for reducing heat loss in very low birth weight infants in incubators |
| Double-bundle versus single-bundle reconstruction for anterior cruciate ligament rupture in adults |
| Double-stapled anastomosis versus mucosectomy and handsewn anastomosis in ileal pouch-anal anastomosis for ulcerative colitis or familial adenomatous polyposis |
| Doubtful effect of lecithin as a treatment for dementia |
| Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease |
| Doxapram treatment for apnea in preterm infants |
| Doxapram versus methylxanthine for apnea in preterm infants |
| Doxazosin for benign prostatic obstruction |
| Doxorubicin after initial treatment for sarcoma reduces risk of recurrence |
| Doxycycline plus ivermectin for preventing and treating river blindness (onchocerciasis) |
| Doxycycline for osteoarthritis |
| Dr Matthew Page on winning the 2018 Bill Silverman Prize |
| Dr. Christian Osadnik wins Monash University 2018 Faculty Early Career Research prize for Cochrane Review |
| Dr. David Tovey awarded Emeritus Editor-in-Chief |
| Drain use after an open appendectomy for complicated appendicitis |
| Drain use after pancreatic surgery |
| Drainage tube placement after lymph gland removal from the armpit for breast cancer |
| Drains are often used after thyroid operations. |
| Drains for leg artery surgery |
| Drains increase the harms to patients undergoing open cholecystectomy |
| Drains versus no drains after pelvic lymphadenectomy to prevent lymphocyst formation in women with gynaecological cancer |
| Drama therapy for schizophrenia or schizophrenia-like illnesses |
| Dressings and securement devices to prevent complications for peripheral arterial catheters |
| Dressings and securement for central venous catheters (CVCs) |
| Dressings and topical agents (creams or lotions) for preventing pressure ulcers |
| Dressings and topical agents (gels, ointments and creams) for treating venous leg ulcers |
| Dressings and topical agents containing hyaluronic acid for chronic wound healing |
| Dressings and topical agents for arterial leg ulcers |
| Dressings and topical agents for donor sites of split-thickness skin grafts |
| Dressings and topical agents for the management of open wounds after surgical treatment for sacrococcygeal pilonidal sinus |
| Dressings and topical agents to help surgical wounds heal by secondary intention |
| Dressings for healing venous leg ulcers |
| Dressings for the prevention of surgical site infection |
| Dressings for treating superficial and partial thickness burns |
| Dressings to treat foot ulcers in people with diabetes |
| Drinking extra water or other non-caloric beverages for promoting weight loss or preventing weight gain |
| Driving assessment for maintaining mobility and safety in drivers with dementia |
| Driving rehabilitation for stroke |
| Droperidol for psychosis-induced aggression or agitation |
| Droperidol for the treatment of nausea and vomiting (sickness) in people with advanced disease |
| Drug and nutritional treatment for McArdle disease |
| Drug combinations for chronic neuropathic pain in adults |
| Drug delivery technique using electrical current for the treatment of non-muscle invasive bladder cancer |
| Drug interventions for deliberately altering blood pressure in acute stroke |
| Drug interventions for the treatment of obesity in children and adolescents |
| Drug interventions versus placebo for the treatment of Raynaud’s phenomenon: generic protocol |
| Drug management for acute tonic-clonic convulsions (fits), including convulsive status epilepticus in children |
| Drug therapy for chronic idiopathic axonal polyneuropathy |
| Drug therapy for delirium in terminally ill adults |
| Drug therapy for Mycetoma |
| Drug therapy for obstructive sleep apnoea in adults |
| Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease |
| Drug therapy for treating idiopathic thrombocytopenic purpura during pregnancy |
| Drug therapy for treating systemic intravascular activation of coagulation in patients with leukemia |
| Drug therapy to treat high levels of uric acid in individuals with high blood pressure |
| Drug treatment for borderline personality disorder |
| Drug treatment for children with bedwetting (nocturnal enuresis) but not including the drug types desmopressin or tricyclics |
| Drug treatment for depression in multiple sclerosis |
| Drug treatment for faecal incontinence in adults |
| Drug treatment for familial amyloid polyneuropathy |
| Drug treatment for lower urinary tract symptoms in women with voiding dysfunction |
| Drug treatment for myotonia (delayed muscle relaxation after contraction) in muscle diseases such as myotonic dystrophy and myotonia congenita |
| Drug treatment for pain in Guillain-Barré syndrome |
| Drug treatment for respiratory syncytial virus lung infections |
| Drug treatment for small abdominal aortic aneurysms |
| Drug treatment for spinal muscular atrophy type I |
| Drug treatment of recurrent abdominal pain in children |
| Drug treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for acute Guillain Barré syndrome |
| Drug treatments and electronic cigarettes for stopping smoking in pregnancy |
| Drug treatments for apathy in Alzheimer's disease |
| Drug treatments for chronic cognitive impairment in traumatic brain injury |
| Drug treatments for chronic hair-pulling (trichotillomania) |
| Drug treatments for constipation caused by antipsychotic medications |
| Drug treatments for dysthymia |
| Drug treatments for pain in children and young people with life-limiting conditions |
| Drug treatments for pain relief in hysterosalpingography |
| Drug treatments for sexual offenders or those at risk of offending |
| Drug treatments that specifically target ammonia for adults with cirrhosis and hepatic encephalopathy |
| Drug treatments to ease breathlessness in cystic fibrosis |
| Drug-based and non-drug-based interventions to improve the bone mineral density in patients living with HIV |
| Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for stenosis of stents in lower limb arteries |
| Drug-eluting bead transarterial chemoembolisation for unresectable hepatocellular carcinoma |
| Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes |
| Drug-eluting stents versus bare-metal stents for stable ischaemic heart disease |
| Drug-free management of young children's pain during medical procedures |
| Drugs (with the exception of botulinum toxin) to treat spasticity after stroke |
| Drugs against parasites for prevention of Chagas heart disease |
| Drugs and natural products for self-harm in adults |
| Drugs and pacemakers for transient loss of consciousness |
| Drugs as treatment for self-injurious behaviour in adults with intellectual disabilities |
| Drugs commonly-used for preventing high altitude illness |
| Drugs for cancer-related fatigue |
| Drugs for discoid lupus erythematosus |
| Drugs for general anaesthesia for caesarean section |
| Drugs for itching in adult palliative care patients |
| Drugs for motor complications in people with Parkinson´s disease who are already taking levodopa |
| Drugs for nocturia in adults |
| Drugs for perineal pain in the early postpartum period: generic protocol |
| Drugs for preventing blood clot dissolution (antifibrinolytic therapy) to reduce the occurrence of rebleeding in aneurysmal subarachnoid haemorrhage |
| Drugs for preventing dry mouth and problems with saliva after radiotherapy |
| Drugs for preventing graft versus host disease |
| Drugs for preventing headache after a lumbar puncture |
| Drugs for preventing hepatitis B recurrence after liver transplantation |
| Drugs for preventing kidney disease in people with diabetes |
| Drugs for preventing lung cancer in healthy people |
| Drugs for preventing major morbidity and mortality related to blood pressure and heart rate changes associated with tracheal intubation |
| Drugs for preventing migraine headaches in children |
| Drugs for preventing nausea and vomiting after surgery |
| Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis |
| Drugs for reducing inflammation in people with familial Mediterranean fever |
| Drugs for reducing iron in patients with acute stroke |
| Drugs for reducing stomach acid for people with cystic fibrosis |
| Drugs for the acute treatment of migraine in children and adolescents |
| Drugs for the prevention and treatment of pruritus in patients receiving neuraxial opioids |
| Drugs for the prevention of postoperative urinary retention in adults |
| Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease) |
| Drugs for treating giardiasis |
| Drugs for treating giardiasis |
| Drugs for treating headache after a lumbar puncture |
| Drugs for treating people with sleepiness during shift work and sleep problems after shift work |
| Drugs for treating Schistosoma mansoni infection |
| Drugs for treating urinary schistosomiasis |
| Drugs for treatment of urinary retention after surgery in adults |
| Drugs for treatment of very high blood pressure during pregnancy |
| Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis |
| Drugs in overactive bladder syndrome |
| Drugs other than those used for epilepsy for treating trigeminal neuralgia |
| Drugs targeting PI3K/AKT/mTOR pathway for locally-advanced, metastatic or recurrent endometrial cancer |
| Drugs that aim to prevent the loss of protein or albumin through urine in people with sickle cell disease |
| Drugs that aim to reduce the loss of water from red blood cells in people with sickle cell disease |
| Drugs that aim to relieve clinical symptoms of tuberous sclerosis complex |
| Drugs that increase alertness (psychostimulants) for excessive daytime sleepiness (hypersomnia) in myotonic dystrophy |
| Drugs that prevent oral bleeding in people using oral anticoagulants undergoing minor oral surgery or dental extractions |
| Drugs that prevent oral bleeding in people with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions |
| Drugs that suppress or modify the immune system for dermatomyositis and polymyositis |
| Drugs that target abnormal growth protein in high-grade, aggressive brain tumours |
| Drugs that target blood vessels in malignant brain tumours |
| Drugs to break down blood clots for people with sudden onset peripheral arterial occlusion |
| Drugs to control the movement of salt in the lungs of people with cystic fibrosis |
| Drugs to dissolve pulmonary embolism (blood clot in the lungs) |
| Drugs to help end amphetamine dependence are not very helpful, and more research is needed. |
| Drugs to help reduce anxiety in people nearing the end of life due to illness |
| Drugs to improve blood flow for people who have poor blood circulation in the veins of their legs |
| Drugs to prevent clots after bleeding in the brain |
| Drugs to prevent heart damage in cancer patients receiving anthracyclines |
| Drugs to prevent malaria in HIV-positive pregnant women. |
| Drugs to prevent nausea and vomiting in children and young people undergoing chemotherapy |
| Drugs to prevent the re-occurrence of narrowing of blood vessels in peripheral arterial disease after the blood vessels have been surgically widened |
| Drugs to reduce bleeding and transfusion in adults undergoing cardiac surgery: a systematic review and network meta-analysis |
| Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta-analysis |
| Drugs to suppress the immune system after lung transplantation in people with cystic fibrosis |
| Drugs to treat acute respiratory distress syndrome in adults |
| Drugs to treat fibroids |
| Drugs to treat phantom limb pain in people with missing limbs |
| Drugs used as add-on therapy to heart procedure following heart attack |
| Drugs used to lower blood pressure do not reduce sudden death |
| Drugs used to treat the symptoms of patellofemoral syndrome have little evidence base |
| Dual antibiotics for bronchiectasis |
| Dual task training for improving balance and gait in people with stroke |
| Duct-to-mucosa pancreaticojejunostomy for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy |
| Duloxetine can improve the quality of life of patients with stress urinary incontinence, long-term effects of the treatment are unclear. |
| Duloxetine for generalised anxiety disorder (GAD) |
| Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia |
| Duloxetine versus other antidepressive agents for depression |
| Duodenum-preserving pancreatic resection versus pancreaticoduodenectomy for chronic pancreatitis |
| Duplex ultrasound for the detection of stenosis after peripheral arterial bypass grafting using autologous vein |
| Duplex ultrasound for the diagnosis of symptomatic deep vein thrombosis in the lower limb |
| Duration of 5FU based chemotherapy in adjuvant setting for colorectal cancer should not exceed 6 months. |
| Duration of antibacterial treatment for uncomplicated urinary tract infection in women |
| Duration of chemotherapy for metastatic breast cancer |
| Duration of therapy for tuberculosis in patients infected with Human Immunodeficiency Virus |
| Duration of treatment for asymptomatic bacteriuria during pregnancy |
| Dying Matters Awareness Week |
| Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis |
| Dynamic exercise therapy for rheumatoid arthritis is effective in increasing aerobic capacity, muscle strength and joint mobility and does not increase disease activity, joint damage or pain. |
| Dysphagia occurs frequently in Parkinson's disease although patients themselves may be unaware of swallowing difficulties. Speech and language therapists in conjunction with nurses and dietiticians use techniques that aim to improve swallowing and reduce |
| E-health interventions for anxiety and depression in children and adolescents with long-term physical conditions |
| Ear drops for the removal of ear wax |
| Earlier compared to later addition of human milk fortifier to human milk to promote growth in preterm infants |
| Early (less than 30 days after the start of chemotherapy) or late (more than 30 days after the start of chemotherapy) chest radiotherapy for patients suffering from limited small cell lung cancer |
| Early (up to seven days) systemic postnatal corticosteroids for preventing bronchopulmonary dysplasia in preterm infants |
| Early additional food and fluids for healthy breastfed full-term infants |
| Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates |
| Early amniocentesis versus transabdominal chorion villus sampling for prenatal diagnosis |
| Early amniotomy and early oxytocin for delay in first stage spontaneous labour compared with routine care |
| Early and late adverse effects on the kidney after treatment for childhood cancer |
| Early Bird Colloquium Registration Deadline: July 25 |
| Early bird registration and stipends now open for the Global Evidence Summit |
| Early bird registration now open for Cochrane Colloquium Santiago |
| Early birth compared with waiting for birth in babies who are thought to be coping poorly towards the end of pregnancy |
| Early birth for babies with gastroschisis |
| Early combination therapy with levodopa and dopamine agonist for preventing motor fluctuations in Parkinson's disease |
| Early compared with delayed oral fluids and food after caesarean section |
| Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants |
| Early discharge of preterm infants from hospital |
| Early discharge with home support of gavage feeding for stable preterm infants who have not established full oral feeds |
| Early elbow movement compared to delayed elbow movement after a broken elbow in adults |
| Early emergency department treatment of acute asthma with systemic corticosteroids |
| Early erythropoiesis-stimulating agents in preterm or low birth weight infants |
| Early excision and grafting for burns |
| Early full enteral feeding for preterm or low birth weight infants |
| Early intensive behavioral intervention (EIBI) for increasing functional behaviors and skills in young children with autism spectrum disorders (ASD) |
| Early intervention (movement or active exercise) for critically ill adults in the intensive care unit |
| Early intervention delivered by parents for young children with autism spectrum disorders |
| Early intervention delivered by parents to young children with autism spectrum disorder |
| Early Intervention for psychosis |
| Early interventions for people at risk of developing psychosis |
| Early intravenous nutrition for the prevention of neonatal jaundice |
| Early introduction of lipids to parenterally-fed preterm infants |
| Early laparoscopy versus observation for patients with acute abdominal pain |
| Early lens extraction compared to standard treatment in acute primary angle closure |
| Early light reduction for preventing retinopathy of prematurity in very low birth weight infants |
| Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants |
| Early nutritional therapy for malnourished or nutritionally at-risk adult medical inpatients |
| Early or delayed removal of gallbladder by key-hole surgery after a sudden episode of gallstone-related pancreatitis |
| Early or delayed surgical removal of appendix in people with symptomatic complicated appendicitis |
| Early palliative care for adults with advanced cancer |
| Early palliative interventions for improving outcomes in people with a primary malignant brain tumour and their carers |
| Early pharmacological interventions for acute traumatic stress symptoms: a network meta-analysis |
| Early pharmacological interventions for preventing post-traumatic stress disorder (PTSD): a network meta-analysis |
| Early planned removal of umbilical venous catheters to prevent infection in newborn infants |
| Early planned removal versus expectant management of peripherally inserted central catheters to prevent infection in newborn infants |
| Early postnatal discharge from hospital for healthy mothers and term infants |
| Early pregnancy screening for identification of undiagnosed pre-existing diabetes to improve maternal and infant health |
| Early psychological interventions to treat acute traumatic stress symptoms |
| Early referral to a specialist doctor for people with kidney disease |
| Early registration for Cochrane Colloquium Edinburgh extended until Friday 22 June |
| Early removal versus expectant management of central venous catheters in newborn infants with bloodstream infection |
